SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipientsDaryl Geers, Corine H. GeurtsvanKessel|Science Immunology|2021Cited by 591
Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cellsCorine H. GeurtsvanKessel, Bart N. Lambrecht|The Journal of Experimental Medicine|2008Cited by 465
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipientsCorine H. GeurtsvanKessel, Rory D. de Vries|Science Immunology|2022Cited by 438
High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patientsSammy Huygens, Bart Rijnders, Arvind Gharbharan et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 23
Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort StudySammy Huygens, Bas B. Oude Munnink, Corine H. GeurtsvanKessel et al.|Clinical Infectious Diseases|2024Cited by 15